-
2
-
-
0021207068
-
Thymosins: Structure, function and therapeutic applications
-
Low TL, Goldstein AL. Thymosins: structure, function and therapeutic applications. Thymus 1984;6:27-42
-
(1984)
Thymus
, vol.6
, pp. 27-42
-
-
Low, T.L.1
Goldstein, A.L.2
-
3
-
-
67649094526
-
From lab to bedside: Emerging clinical applications of thymosin alpha 1
-
Goldstein AL, Goldstein AL. From lab to bedside: emerging clinical applications of thymosin alpha 1. Expert Opin Biol Ther 2009;9:593-608
-
(2009)
Expert Opin Biol Ther
, vol.9
, pp. 593-608
-
-
Goldstein, A.L.1
Goldstein, A.L.2
-
4
-
-
0028916425
-
Hepatitis B virus immunopathogenesis
-
Chisari FV, Ferrari C. Hepatitis B virus immunopathogenesis. Annu Rev Immunol 1995;13:29-60
-
(1995)
Annu Rev Immunol
, vol.13
, pp. 29-60
-
-
Chisari, F.V.1
Ferrari, C.2
-
5
-
-
0025880857
-
Low thymosin alpha-1 concentrations in patients chronically infected with the hepatitis B virus
-
Sherman KE, Jones CC, Goldstein AL, et al. Low thymosin alpha-1 concentrations in patients chronically infected with the hepatitis B virus. Viral Immunol 1991;4:195-9
-
(1991)
Viral Immunol
, vol.4
, pp. 195-199
-
-
Sherman, K.E.1
Jones, C.C.2
Goldstein, A.L.3
-
6
-
-
0036905661
-
Thymosin-alpha1 increases intrahepatic NKT cells and CTLs in patients with chronic hepatitis B
-
Sugahara S, Ichida T, Yamagiwa S, et al. Thymosin-alpha1 increases intrahepatic NKT cells and CTLs in patients with chronic hepatitis B. Hepatol Res 2002;24:346-54
-
(2002)
Hepatol Res
, vol.24
, pp. 346-354
-
-
Sugahara, S.1
Ichida, T.2
Yamagiwa, S.3
-
7
-
-
0035179789
-
Thymosin alpha1 accelerates restoration of T cell-mediated neutralizing antibody response in immunocompromised hosts
-
Li CL, Zhang T, Saibara T, et al. Thymosin alpha1 accelerates restoration of T cell-mediated neutralizing antibody response in immunocompromised hosts. Int Immunopharmacol 2002;2:39-46
-
(2002)
Int Immunopharmacol
, vol.2
, pp. 39-46
-
-
Li, C.L.1
Zhang, T.2
Saibara, T.3
-
8
-
-
0026042722
-
Thymosin treatment of chronic hepatitis B: A placebo-controlled pilot trial
-
Mutchnick MG, Appelman HD, Chung HT, et al. Thymosin treatment of chronic hepatitis B: a placebo-controlled pilot trial. Hepatology 1991;14:409-15
-
(1991)
Hepatology
, vol.14
, pp. 409-415
-
-
Mutchnick, M.G.1
Appelman, H.D.2
Chung, H.T.3
-
9
-
-
0031596591
-
Efficacy of thymosin alpha1 in patients with chronic hepatitis B: A randomized, controlled trial
-
The first confirmed report of Thymosin a-1 (Ta-1) on chronic hepatitis B (CHB) compared with no treatment
-
Chien RN, Liaw YF, Chen TC, et al. Efficacy of thymosin alpha1 in patients with chronic hepatitis B: a randomized, controlled trial. Hepatology 1998;27:1383-7. The first confirmed report of Thymosin a-1 (Ta-1) on chronic hepatitis B (CHB) compared with no treatment.
-
(1998)
Hepatology
, vol.27
, pp. 1383-1387
-
-
Chien, R.N.1
Liaw, Y.F.2
Chen, T.C.3
-
10
-
-
4244168258
-
Sustained response to thymosin therapy in patients with chronic hepatitis B
-
Mutchnick MG, Jaurequi JI, Shafritz DA. Sustained response to thymosin therapy in patients with chronic hepatitis B. Hepatology 1992;16:66A
-
(1992)
Hepatology
, vol.16
-
-
Mutchnick, M.G.1
Jaurequi, J.I.2
Shafritz, D.A.3
-
11
-
-
0032585756
-
Thymosin alpha1 treatment of chronic hepatitis B: Results of a phase III multicentre, randomized, double-blind and placebo-controlled study
-
Mutchnick MG, Lindsay KL, Schiff ER, et al. Thymosin alpha1 treatment of chronic hepatitis B: results of a phase III multicentre, randomized, double-blind and placebo-controlled study. J Viral Hepat 1999;6:397-403
-
(1999)
J Viral Hepat
, vol.6
, pp. 397-403
-
-
Mutchnick, M.G.1
Lindsay, K.L.2
Schiff, E.R.3
-
12
-
-
0034112421
-
A randomized, controlled study of thymosin-alpha1 therapy in patients with anti-HBe, HBV-DNA-positive chronic hepatitis B
-
Zavaglia C, Severini R, Tinelli C, et al. A randomized, controlled study of thymosin-alpha1 therapy in patients with anti-HBe, HBV-DNA-positive chronic hepatitis B. Dig Dis Sci 2000;45:690-6
-
(2000)
Dig Dis Sci
, vol.45
, pp. 690-696
-
-
Zavaglia, C.1
Severini, R.2
Tinelli, C.3
-
13
-
-
0035663014
-
The efficacy of thymosin in the treatment of chronic hepatitis B virus infection: A meta-analysis
-
The highest grade evidence of Ta-1 on CHB compared with no treatment
-
Chan HL, Tang JL, Tam W, et al. The efficacy of thymosin in the treatment of chronic hepatitis B virus infection: a meta-analysis. Aliment Pharmacol Ther 2001;15:1899-905 The highest grade evidence of Ta-1 on CHB compared with no treatment.
-
(2001)
Aliment Pharmacol Ther
, vol.15
, pp. 1899-1905
-
-
Chan, H.L.1
Tang, J.L.2
Tam, W.3
-
14
-
-
33751016826
-
Hepatitis B virus genotype B is associated with better response to thymosin alpha1 therapy than genotype C
-
Chien RN, Lin CY, Yeh CT, et al. Hepatitis B virus genotype B is associated with better response to thymosin alpha1 therapy than genotype C. J Viral Hepat 2006;13:845-50
-
(2006)
J Viral Hepat
, vol.13
, pp. 845-850
-
-
Chien, R.N.1
Lin, C.Y.2
Yeh, C.T.3
-
15
-
-
10144241676
-
A randomized controlled trial of thymosin-alpha1 versus interferon alfa treatment in patients with hepatitis B e antigen antibody-and hepatitis B virus DNA-positive chronic hepatitis B
-
Andreone P, Cursaro C, Gramenzi A, et al. A randomized controlled trial of thymosin-alpha1 versus interferon alfa treatment in patients with hepatitis B e antigen antibody-and hepatitis B virus DNA-positive chronic hepatitis B. Hepatology 1996;24:774-7
-
(1996)
Hepatology
, vol.24
, pp. 774-777
-
-
Andreone, P.1
Cursaro, C.2
Gramenzi, A.3
-
16
-
-
0034956179
-
A randomized controlled clinical trial on the treatment of thymosin--alpha 1 versus interferon-alpha in patients with hepatitis B
-
You J, Zhuang L, Tang BZ, et al. A randomized controlled clinical trial on the treatment of thymosin--alpha 1 versus interferon-alpha in patients with hepatitis B. World J Gastroenterol 2001;7:411-14
-
(2001)
World J Gastroenterol
, vol.7
, pp. 411-414
-
-
You, J.1
Zhuang, L.2
Tang, B.Z.3
-
17
-
-
20044361999
-
A randomized, controlled, clinical study of thymosin alpha-1 versus interferonalpha in patients with chronic hepatitis B lacking HBeAg in China
-
You J, Zhuang L, Cheng HY, et al. A randomized, controlled, clinical study of thymosin alpha-1 versus interferonalpha in patients with chronic hepatitis B lacking HBeAg in China. J Chin Med Assoc 2005;68:65-72
-
(2005)
J Chin Med Assoc
, vol.68
, pp. 65-72
-
-
You, J.1
Zhuang, L.2
Cheng, H.Y.3
-
18
-
-
0034948762
-
Preliminary results of Thymosin-a1 versus interferon-alpha-treatment in patients with HBeAg negative and serum HBV DNA positive chronic hepatitis B
-
Zhuang L, You J, Tang BZ, et al. Preliminary results of Thymosin-a1 versus interferon-alpha-treatment in patients with HBeAg negative and serum HBV DNA positive chronic hepatitis B. World J Gastroenterol 2001;7:407-10
-
(2001)
World J Gastroenterol
, vol.7
, pp. 407-410
-
-
Zhuang, L.1
You, J.2
Tang, B.Z.3
-
19
-
-
38349056857
-
Comparison of the efficacy of thymosin alpha-1 and interferon alpha in the treatment of chronic hepatitis B: A meta-analysis
-
The highest grade evidence of Ta-1 on CHB compared with interferon
-
Yang YF, Zhao W, Zhong YD, et al. Comparison of the efficacy of thymosin alpha-1 and interferon alpha in the treatment of chronic hepatitis B: a meta-analysis. Antiviral Res 2008;77:136-41. The highest grade evidence of Ta-1 on CHB compared with interferon.
-
(2008)
Antiviral Res
, vol.77
, pp. 136-141
-
-
Yang, Y.F.1
Zhao, W.2
Zhong, Y.D.3
-
20
-
-
67649920809
-
Treatment with lamivudine versus lamivudine and thymosin alpha-1 for e antigen-positive chronic hepatitis B patients: A meta-analysis
-
The highest grade evidence of Ta-1 and nucleoside analog combination compared with nucleoside analog alone
-
Zhang YY, Chen EQ, Yang J, et al. Treatment with lamivudine versus lamivudine and thymosin alpha-1 for e antigen-positive chronic hepatitis B patients: a meta-analysis. Virol J 2009;6:63. The highest grade evidence of Ta-1 and nucleoside analog combination compared with nucleoside analog alone.
-
(2009)
Virol J
, vol.6
, pp. 63
-
-
Zhang, Y.Y.1
Chen, E.Q.2
Yang, J.3
-
21
-
-
0036633685
-
Thymosin alpha-1 and famciclovir combination therapy activates T-cell response in patients with chronic hepatitis B virus infection in immunetolerant phase
-
Lau GK, Nanji A, Hou J, et al. Thymosin alpha-1 and famciclovir combination therapy activates T-cell response in patients with chronic hepatitis B virus infection in immunetolerant phase. J Viral Hepat 2002;9:280-7
-
(2002)
J Viral Hepat
, vol.9
, pp. 280-287
-
-
Lau, G.K.1
Nanji, A.2
Hou, J.3
-
22
-
-
0038082975
-
Long-term outcomes of thymosin-alpha 1 and interferon alpha-2b combination therapy in patients with hepatitis B e antigen negative chronic hepatitis B
-
Saruc M, Ozden N, Turkel N, et al. Long-term outcomes of thymosin-alpha 1 and interferon alpha-2b combination therapy in patients with hepatitis B e antigen negative chronic hepatitis B. J Pharm Sci 2003;92:1386-95
-
(2003)
J Pharm Sci
, vol.92
, pp. 1386-1395
-
-
Saruc, M.1
Ozden, N.2
Turkel, N.3
-
23
-
-
0036016778
-
Combination thymosin-alpha 1 and interferon-alpha 2b in the treatment of anti-HBe-positive chronic hepatitis B in Turkey
-
Saruc M, Yuceyar H, Kucukmetin N, et al. Combination thymosin-alpha 1 and interferon-alpha 2b in the treatment of anti-HBe-positive chronic hepatitis B in Turkey. Hepatogastroenterology 2002;49:798-802
-
(2002)
Hepatogastroenterology
, vol.49
, pp. 798-802
-
-
Saruc, M.1
Yuceyar, H.2
Kucukmetin, N.3
-
24
-
-
80054761510
-
Treatment with interferon and thymosin alpha-1 versus interferon monotherapy for HBeAg positive chronic hepatitis B: A meta-analysis
-
The summerise of Chinese study of Ta-1 and interferon combination compared with interferon alone on CHB
-
Mao HY, Shi TD. Treatment with interferon and thymosin alpha-1 versus interferon monotherapy for HBeAg positive chronic hepatitis B: a meta-analysis. Zhonghua Gan Zang Bing Za Zhi 2011;19:29-33 The summerise of Chinese study of Ta-1 and interferon combination compared with interferon alone on CHB.
-
(2011)
Zhonghua Gan Zang Bing Za Zhi
, vol.19
, pp. 29-33
-
-
Mao, H.Y.1
Shi, T.D.2
-
25
-
-
84865778313
-
Efficacy of thymosin a-1 plus peginterferon a-2a combination therapy compared with peginterferon a-2a monotherapy in HBeAg-positive chronic hepatitis B: A prospective, multicenter, randomized, open-label study
-
Kim BH, Lee YJ, Kim W, et al. Efficacy of thymosin a-1 plus peginterferon a-2a combination therapy compared with peginterferon a-2a monotherapy in HBeAg-positive chronic hepatitis B: a prospective, multicenter, randomized, open-label study. Scand J Gastroenterol 2012;47:1048-55
-
(2012)
Scand J Gastroenterol
, vol.47
, pp. 1048-1055
-
-
Kim, B.H.1
Lee, Y.J.2
Kim, W.3
-
26
-
-
84865376141
-
Asian-Pacific consensus statement on the management of chronic hepatitis B: A 2012 update
-
Liaw YF, Gao JH, Piratvisuth T, et al. Asian-Pacific consensus statement on the management of chronic hepatitis B: a 2012 update. Hepatol Int 2012;6:531-61
-
(2012)
Hepatol Int
, vol.6
, pp. 531-561
-
-
Liaw, Y.F.1
Gao, J.H.2
Piratvisuth, T.3
|